Table 2.
Percentages of cancer screening use (95% confidence interval) by cognitive impairment status among screening-eligible populations
| Cancer screening | Cognitive impairment | p-value | |||
|---|---|---|---|---|---|
| 2018 | |||||
| Overall (n = 5687) |
Severely impaired (n = 157) |
Mildly impaired (n = 1102) | Unimpaired (n = 4428) | ||
| Mammogram | 72.9% (71.4–74.3%) | 58.3% (48.0–68.6%) | 71.6% (68.3–74.8%) | 73.7% (72.1–75.4%) | = 0.002 |
| Overall (n = 10,811) |
Severely impaired (n = 259) |
Mildly impaired (n = 1980) | Unimpaired (n = 8572) | ||
| Colonoscopy | 60.6% (59.4–61.9%) | 63.6% (56.2–70.9%) | 61.8% (59.0–64.6%) | 60.3% (59.0–61.6%) | = 0.436 |
| 2019 | |||||
| Overall (n = 7278) |
Severely impaired (n = 140) |
Mildly impaired (n = 1305) | Unimpaired (n = 5833) | ||
| Mammogram | 76.5% (75.3–77.7%) | 66.1% (56.6–75.6%) | 74.1% (71.2–77.4%) | 77.2% (75.9–78.6%) | = 0.008 |
| Overall (n = 13,971) |
Severely impaired (n = 271) |
Mildly impaired (n = 2358) | Unimpaired (n = 11,342) | ||
| Colonoscopy | 57.9% (56.8–58.9%) | 56.9% (49.3–64.5%) | 58.3% (55.6–60.9%) | 57.8% (56.7–58.9%) | = 0.918 |